These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 3306422)

  • 1. Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection.
    Fung JJ; Demetris AJ; Porter KA; Iwatsuki S; Gordon RD; Esquivel CO; Jaffe R; Tzakis A; Shaw BW; Starzl TE
    Nephron; 1987; 46 Suppl 1(Suppl 1):19-33. PubMed ID: 3306422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibody therapy with ciclosporin and steroids in nonmatched cadaveric renal transplants.
    Gordon RD; Starzl TE; Fung JJ; Iwatsuki S; Esquivel CO; Tzakis A; Todo S
    Nephron; 1987; 46 Suppl 1(Suppl 1):56-9. PubMed ID: 3306426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibody OKT3 therapy in pediatric kidney transplant recipients.
    Leone MR; Barry JM; Alexander SR; Melvin T; Striegel J; Reller K; Henell KR; Kimball J; Funnell MB; Goldstein G
    J Pediatr; 1990 May; 116(5):S86-91. PubMed ID: 2139465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of a brief steroid trial before initiating OKT3 therapy for renal allograft rejection.
    Thistlethwaite JR; Stuart JK; Mayes JT; Gaber AO; Stuart FP
    Am J Kidney Dis; 1988 Feb; 11(2):94-8. PubMed ID: 3277413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized clinical trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants.
    Ortho Multicenter Transplant Study Group
    N Engl J Med; 1985 Aug; 313(6):337-42. PubMed ID: 2861567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized clinical trial comparing OKT3 and steroids for treatment of hepatic allograft rejection.
    Cosimi AB; Cho SI; Delmonico FL; Kaplan MM; Rohrer RJ; Jenkins RL
    Transplantation; 1987 Jan; 43(1):91-5. PubMed ID: 3099442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized clinical trial comparing OKT3 and steroids for treatment of hepatic allograft rejection.
    Cosimi AB; Cho SI; Delmonico FL; Kaplan MM; Rohrer RJ; Jenkins RL
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2431-3. PubMed ID: 3079083
    [No Abstract]   [Full Text] [Related]  

  • 8. Anti-rejection therapy in renal transplantation: Use of the monoclonal antibody OKT3.
    Nicholson ML; Donnelly PK; Veitch PS; Bell PR
    Nephrol Dial Transplant; 1991; 6(4):275-9. PubMed ID: 1881582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized clinical trial of prophylactic OKT3 monoclonal antibody in liver allograft recipients.
    Cosimi AB; Jenkins RL; Rohrer RJ; Delmonico FL; Hoffman M; Monaco AP
    Arch Surg; 1990 Jun; 125(6):781-4; discussion 785. PubMed ID: 2111982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OKT3 monoclonal antibody reversal of renal and hepatic rejection in pediatric patients.
    Goldstein G; Kremer AB; Barnes L; Hirsch RL
    J Pediatr; 1987 Dec; 111(6 Pt 2):1046-50. PubMed ID: 3316579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed response to orthoclone OKT3 treatment for renal allograft rejection resistant to steroid and antilymphocyte globulin.
    Oh CS; Sollinger HW; Stratta RJ; Kalayoglu M; Belzer FO
    Transplantation; 1988 Jan; 45(1):65-7. PubMed ID: 3276065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The selective use of antilymphocyte serum for cyclosporine treated patients with renal allograft dysfunction.
    Delmonico FL; Auchincloss H; Rubin RH; Russell PS; Tolkoff-Rubin N; Fang LT; Cosimi AB
    Ann Surg; 1987 Nov; 206(5):649-54. PubMed ID: 3314751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OKT3 treatment of steroid-resistant renal allograft rejection.
    Thistlethwaite JR; Gaber AO; Haag BW; Aronson AJ; Broelsch CE; Stuart JK; Stuart FP
    Transplantation; 1987 Feb; 43(2):176-84. PubMed ID: 3544373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OKT3: First-dose safety and success.
    Cosimi AB
    Nephron; 1987; 46 Suppl 1():12-8. PubMed ID: 3306421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of low-dose cyclosporine on the outcome of treatment with OKT3 for acute renal allograft rejection.
    Hricik DE; Zarconi J; Schulak JA
    Transplantation; 1989 Feb; 47(2):272-7. PubMed ID: 2493175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orthoclone OKT3 treatment of acute renal allograft rejection in patients receiving maintenance cyclosporine therapy.
    Hirsch RL; Layton PC; Barnes LA; Kremer AB; Goldstein G
    Transplant Proc; 1987 Apr; 19(2 Suppl 1):32-6. PubMed ID: 3105138
    [No Abstract]   [Full Text] [Related]  

  • 17. Effectiveness of a second course of OKT3 monoclonal anti-T cell antibody for treatment of renal allograft rejection.
    Norman DJ; Shield CF; Henell KR; Kimball J; Barry JM; Bennett WM; Leone M
    Transplantation; 1988 Oct; 46(4):523-9. PubMed ID: 3140448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. OKT3 in the reversal of acute hepatic allograft rejection.
    Esquivel CO; Fung JJ; Markus B; Iwatsuki S; Gordon RD; Makowka L; Marsh JW; Tzakis AG; Todo S; Starzl TE
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2443-6. PubMed ID: 3103297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infection and rejection of primary hepatic transplant in 93 consecutive patients treated with triple immunosuppressive therapy.
    Ascher NL; Stock PG; Bumgardner GL; Payne WD; Najarian JS
    Surg Gynecol Obstet; 1988 Dec; 167(6):474-84. PubMed ID: 3055368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyclonal and monoclonal antibodies for treating acute rejection episodes in kidney transplant recipients.
    Webster AC; Wu S; Tallapragada K; Park MY; Chapman JR; Carr SJ
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD004756. PubMed ID: 28731207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.